来自千足动物防御分泌物的神经调节化物
Carla Menegatti1, Jared S Wood2, Paige Banks1
1Department of Chemistry, Virginia Tech, Blacksburg, Virginia 24061, United States.
Journal of natural products
|January 24, 2025
概括
千足动物分泌复杂的类类化合物,如新发现的ischnocybines,使捕食者迷失方向. 伊什诺基宾A特别与西格玛-1神经受体结合,为千足动物的防御机制提供了洞察力.
科学领域:
- 自然产品化学 自然产品化学
- 化学生态化学生态学
- 神经生物学 神经生物学 神经生物学
背景情况:
- 千足动物产生各种化学防御,包括研究较少的类化物.
- 众所周知,类化合物会使捕食者失去方向,但它们的特定生化标仍然未知.
研究的目的:
- 为了研究千足的防御分泌物.
- 为了阐明来自该物种的新型类类化合物的结构和特性.
- 为了识别这些防御化合物的生物化学目标.
主要方法:
- 使用各种分析技术,分离和阐明类化合物的结构.
- 对分泌物对抗的防御活动的评估.
- 神经受体结合测试以评估与西格玛-1和西格玛-2受体的相互作用.
主要成果:
- 确定了四种新的,高度氧化的类类,称为ischnocybines.
- 伊斯克诺西宾被积极分泌,并表现出抗迷失方向的特性.
- 伊什诺基宾A对西格玛-1神经受体表现出强有力的和选择性的结合.
结论:
- 发现的ischnocybines是迄今为止发现的最复杂的千足类化物.
- 这项研究提供了第一个潜在的生物化学标 (sigma-1受体) 千足类类防御.
- 这些发现有助于更好地理解化学生态和无脊椎动物防御机制的演变.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.5K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.5K
Neuromuscular Junction And Blockade
2.8K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
2.8K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
852
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
852
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
388
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
388
Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
613
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
613


